The city of Tondabayashi in Osaka is excited to announce a new inbound tour by "SABIWabisabi," aimed at revitalizing the ...
Tumors shrank in 91% of taletrectinib-treated patients with advanced ROS1-positive NSCLC who were ROS1 TKI-naïve and 52% of ...
The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been filed in the U ...
Ankyra Therapeutics, a clinical-stage oncology company developing anchored immunotherapies to improve the therapeutic window for immuno-oncology drugs ...
Tempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverage ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced longer-term efficacy and safety ...
(ビジネスワイヤ) -- ネットワークの未来を構築するクラウドネイティブなネットワーク・インフラストラクチャ・プロバイダーであるマべニアは、オムディアによる最新の「市場環境:2024年RANベンダー」(Market Landscape: RAN Vendors 2024)レポートにおいて、「主要なチ ...
Postmedia Network Inc., a wholly owned subsidiary of Postmedia Network Canada Corp. (“Postmedia” or “the Company”) today announced that it has closed ...
GUANGZHOU, China--(BUSINESS WIRE)--Coinciding with the Chinese Year of the Dragon in 2024, in order to celebrate the 40th ...
Study shows that FPM data can be reliably and quickly generated even through minimally invasive small-needle biopsies, which may expand the accessibility of FPM to provide personalized treatment ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 3 ECHELON-3 study of ADCETRIS ® (brentuximab vedotin) in combination with ...
Ault Disruptive Technologies Corporation, a special purpose acquisition company (the “Company”), today announced that in view ...